Lunan Pharma in International Platform
New Media Department Yu Jie, Duan Yuqing April 21, 2021
Lunan Pharmaceutical has established an international drug research and development center, which is in line with the international standards, and established a quality assurance system that is in line with the international advanced quality supervision concepts such as FDA, ICH and EDQM. 120 scientific and technological achievements have passed expert appraisal, and 45 have reached the international advanced level.
By 2021, Lunan Pharma has passed the official on-site inspections in Japan, South Korea, the United States, Colombia, Mexico, Indonesia, Pakistan, Nigeria, the Philippines and other countries, and passed the supplier audits of dozens of world-renowned customers. 2 varieties have passed PDMA field inspection in Japan, 3 varieties have passed KFDA field inspection in Korea, 5 API products have obtained CEP certification in EU, 13 products have been registered in India, 17 products have obtained DMF number in the US, Ruizhi ® Rosuvastatin Calcium Tablet has been approved by ANDA in the US, Ezetimibe Tablets are approved by the MA of Germany and the Netherlands.
The products of Lunan Pharma are exported to nearly 100 countries and regions such as European Union, the United States, Japan, India and so on. The national pharmaceutical brand is shining in the world, and Lunan Pharma has become an active new force in the field of medicine in the world.